MolNFT v1 · #120491 · protein
Trimethoxy-ring inhibitor in complex with the first bromodomain of BRD4
5H21 · Bromodomain-containing protein 4: “Trimethoxy-ring inhibitor in complex with the first bromodomain of BRD4”. X-ray diffraction, 1 ligand (RMR), 1 pocket (best druggability 0.55). MolNFT v1 #120491 on GenesisL1: 3D structure, binding…
- PDB
- 5H21
- Type
- protein
- Length
- 124 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Bromodomain-containing protein 4
- UniProt
- O60885
- Ligands
- RMR
- Pockets
- 1 · best druggability 0.55
Structure
x-ray diffraction · 1 distinct chain · 57% helix, 0% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Bromodomain-containing protein 4 | protein | 124 | 57% helix, 0% strand | O60885 |
Ligands and binding sites
- RMR · 3,4,5-trimethoxy-~{N}-(2-thiophen-2-ylethyl)benzamide · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 117 | 0.55 | 0.83 | 22 | RMR |
Compared structures
- 5H21 · Trimethoxy-ring inhibitor in complex with the first bromodomain of BRD4 · the same entry in another collection · chain A against A, TM-score 1.00
- O60885 · AlphaFold monomer V2.0 prediction for bromodomain-containing protein 4 (O60885) · a predicted model of the same protein · chain A against A, TM-score 0.97
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt O60885
- Elsewhere: RCSB PDB 5H21 · PDBe 5H21 · UniProt O60885
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.